Application

18235976 · NOVEL N-ACYL-[3-SUBSTITUTED]-[8-SUBSTITUTED]-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS

Filed 2023-08-21 · Abandoned The official file ↗ · Art unit 1624 · Examiner Douglas M Willis Typical · CPC C07D 487/04 · Ogeda SA · Astellas US LLC, Patents Department

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

14.5 mo

to disposition 22.7 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.